These effects, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the idea of targeting ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Issues. Publishing this review means that you https://gustavea172vmc7.wikifiltraciones.com/user